ReviewJournal of clinical medicine2020

Immune Dysregulation in HFpEF: A Target for Mesenchymal Stem/Stromal Cell Therapy.

Ruxandra I Sava et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.